CARL M. DeFRANCO
56 IP cases indexed. Covers patent matters.
Cases Presided Over
56 cases indexed | Page 2 of 2
Skechers U.S.A., Inc. v.Nike, Inc.
The PTAB granted institution of Inter Partes Review for Skechers against Nike regarding a footwear patent (9730484). The Board determined that Skechers met the threshold by showing a reasonable likelihood of unpatentability over prior art references like Dua and Hong.
GD Energy Products, LLC v.Kerr Machine Company
GD Energy Products successfully petitioned the PTAB to institute an IPR against Kerr Machine Company's pump patent, alleging obviousness under 35 U.S.C. § 103. The Board found it more likely than not that at least one claim would be unpatentable over various prior art references related to fluid end assemblies.
Jeisys Medical Inc. et al. v.Serendia, LLC
EndyMed Medical and Serendia settled their inter partes review disputes over U.S. Patent 9,775,774, leading the PTAB to terminate the proceedings and keep the settlement confidential.
Jeisys Medical Inc. et al. v.Serendia, LLC
Serendia and Jeisys Medical settled their IPR dispute over U.S. Patent 9,320,536, leading the PTAB to terminate the proceeding.
Ilooda Co., Ltd. et al. v.Serendia, LLC
The Board granted a joint motion to terminate the IPR as to Jeisys Medical Inc. following a settlement with Serendia, while allowing EndyMed petitioners to continue the review.
EndyMed Medical Ltd. et al. v.Serendia, LLC
EndyMed Medical and Serendia settled their inter partes review of U.S. Patent 9,480,836, leading the PTAB to terminate the proceeding. The settlement agreement is treated as confidential business information.
Clearwater Paper Corporation v.--
The PTAB granted institution of IPR for Clearwater Paper Corporation against Graphic Packaging International LLC, challenging claims related to biodegradable paper cups based on prior art references Cleveland and Nakagawa.
Jeisys Medical Inc. et al. v.Serendia, LLC
The Board granted a joint motion to terminate the IPR only for Jeisys Medical Inc. after a settlement with Serendia, while EndyMed remains as a petitioner. The settlement agreement was ordered confidential.
Trove Brands, LLC v.CamelBak Products, LLC
Trove Brands' IPR challenge against CamelBak Products regarding a drinkware patent was denied by the PTAB. The Board found that the Petitioner failed to establish a reasonable likelihood of prevailing on any ground, despite arguments concerning functional equivalence in user release mechanisms over prior art like Kiyota and Ribarits.
TROVE BRANDS, LLC v.CamelBak Products, LLC
The PTAB denied TROVE BRANDS' request to institute IPR against CamelBak Products regarding drinkware cap mechanisms. The Board found that the Petitioner failed to show a reasonable likelihood of unpatentability over combinations of prior art references like Kiyota, Choi, Park, and Ribarits.
Tesla Inc. v.Charge Fusion Technologies, LLC
Tesla Inc.'s petition against Charge Fusion Technologies, LLC was instituted by the PTAB, finding a reasonable likelihood that the patent claims are unpatentable as obvious. The Board focused on how prior art references could combine to render independent claims obvious, specifically regarding charging system features.
Tesla, Inc. v.Charge Fusion Technologies, LLC
Tesla successfully challenged Charge Fusion Technologies' patent claims in a PTAB institution decision. The Board found sufficient motivation to combine prior art references, rendering numerous independent and dependent claims obvious under 35 U.S.C. § 103. This outcome significantly weakens the asserted patent portfolio for Charge Fusion.
Trove Brands, LLC v.CamelBak Products, LLC
Trove Brands' IPR petition against CamelBak Products regarding mouthpiece and cap assemblies was denied by the PTAB. The Board found that petitioner failed to meet the statutory threshold for institution, specifically rejecting obviousness grounds under 35 U.S.C. § 103.
Intelligent Wellhead Systems, Inc. et al. v.Downing Wellhead Equipment, LLC et al.
The PTAB instituted PGR on claims 1-78 of the '952 patent after reviewing multiple grounds, including eligibility (§ 101), obviousness (§ 103), and written description/enablement (§ 112). The Board found a likelihood of success for Petitioner despite arguments from Patent Owner regarding prior art limitations.
Ilooda Co., Ltd. et al. v.Serendia, LLC
EndyMed Medical and Serendia, LLC entered a settlement that resolved all disputes over three patents, leading the PTAB to terminate the associated IPRs. The settlement agreement was deemed confidential business information.
Jeisys Medical Inc. et al. v.Serendia, LLC
The PTAB granted a settlement‑based termination for Jeisys Medical in three IPRs while allowing the proceedings to continue for EndyMed. The settlement agreement was ordered to be kept confidential.
Ilooda Co., Ltd. et al. v.Serendia, LLC
The PTAB granted a joint motion to terminate the IPR for Jeisys Medical Inc. after the parties settled their dispute. The settlement agreement was ordered to be kept confidential, and the proceeding remains open only for EndyMed petitioners.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Endymed Medical and Serendia settled their inter partes review of U.S. Patent 9,480,836, leading the PTAB to terminate the proceeding under 35 U.S.C. § 317.
Applied Concepts Inc. v.Kustom Signals Inc.
Applied Concepts and Kustom Signals jointly moved to terminate two inter partes review proceedings after reaching a settlement. The Board granted the termination, citing good cause and public policy favoring settlement.
EndyMed Medical Ltd. et al. v.Serendia, LLC
EndyMed Medical and Serendia reached a settlement that resolved all disputes over U.S. Patent No. 10,869,812. The Board granted a joint motion to terminate the instituted IPRs and treated the settlement agreement as confidential business information.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear settled their inter partes review of U.S. Patent 9,295,288. The Board terminated the IPR by joint motion, treating the settlement agreement as confidential.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear reached a confidential settlement, prompting the PTAB to terminate the IPRs covering SherryWear’s footwear patent (U.S. 10,219,550). The Board cited statutory authority to end the review before any merits were decided.
Pascal Technologies v.Cambridge Enterprise Limited et al.
Pascal Technologies and Cambridge Enterprise Limited, along with two universities, settled their IPR dispute over U.S. Patent 11,230,656. The Board terminated the proceeding and treated the settlement agreement as confidential business information.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear reached a confidential settlement, leading the PTAB to terminate a series of inter partes reviews, including the one covering patent 10,219,551. The termination was entered under 35 U.S.C. §317 after the trials had already been instituted.
Nike, Inc. v.SherryWear, LLC et al.
Nike and SherryWear settled their IPR dispute over patent 9,808,036 B1. The Board granted a joint motion to terminate the proceedings, treating the settlement agreement as confidential.
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear entered a confidential settlement, prompting the PTAB to terminate the pending IPRs, including the case involving patent 10,869,510.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.